All Stories

  1. Hyperglycaemia in comatose survivors of out-of-hospital cardiac arrest
  2. Endovascular cooling catheter related thrombosis in patients undergoing therapeutic hypothermia for out of hospital cardiac arrest
  3. Performance of transcatheter aortic valve implantation in patients with bicuspid aortic valve: Systematic review
  4. Left Atrial Myxoma: A Rare Cause of Dyspnea
  5. A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study
  6. Therapeutic Hypothermia in Post Cardiac Arrest
  7. Three year clinical outcomes with zotarolimus (Endeavor) drug-eluting stents in an unrestricted contemporary practice
  8. Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery?: exploratory analysis from the CASCADE trial
  9. The impact of therapeutic hypothermia as adjunctive therapy in a regional primary PCI program
  10. TICAGRELOR VERSUS TICAGRELOR AND CLOPIDOGREL IN PATIENTS UNDERGOING PRIMARY PCI: A PLATELET REACTIVITY PHARMACODYNAMICS STUDY
  11. A PHARMACOGENOMIC APPROACH TO ANTIPLATELET THERAPY IN STEMI PATIENTS: REASSESSMENT OF ANTI-PLATELET THERAPY USING AN INDIVIDUALIZED STRATEGY IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (THE RAPID STEMI STUDY)
  12. Response to letter: “Role of intra-aortic balloon pumping on cerebral perfusion after cardiac arrest”
  13. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI Study)
  14. Lessons Learned from the Ottawa Regional STEMI Program
  15. TCT-487 Door-to-Balloon Time as a Function of Mode of Referral: Results from the Ontario Provincial Cardiac Care Network Database
  16. TCT-736 Markedly Reduced Platelet Inhibition with Clopidogrel Given To Patients Undergoing Therapeutic Hypothermia Post Cardiac Arrest
  17. Reduction in Mortality as a Result of Direct Transport From the Field to a Receiving Center for Primary Percutaneous Coronary Intervention
  18. Transradial Versus Transfemoral Artery Approach for Coronary Angiography and Percutaneous Coronary Intervention in the Extremely Obese
  19. Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
  20. TIMING OF ANGIOGRAPHY AND CLINICAL OUTCOMES AFTER FIBRINOLYSIS: A PATIENT-LEVEL ANALYSIS OF RANDOMIZED EARLY INVASIVE CLINICAL TRIALS
  21. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug‐eluting stents
  22. Statin Therapy and Saphenous Vein Graft Disease After Coronary Bypass Surgery: Analysis From the CASCADE Randomized Trial
  23. STEM CELL MOBILIZATION BY GRANULOCYTE COLONY STIMULATING FACTOR POST MYOCARDIAL INFARCTION TO PROMOTE MYOCYTE REPAIR
  24. CORONARY ANGIOGRAPHY / INTERVENTION IN PATIENTS WITH EXTREME OBESITY (BMI ≥ 40): RADIAL VERSUS FEMORAL APPROACH
  25. CLINICAL OUTCOMES OF PATIENTS WHO DEVELOP CARDIOGENIC SHOCK (CS) AFTER AN ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) WITHIN A DEDICATED CITYWIDE PRIMARY PERCUTANEOUS CORONARY INTERVENTION PROTOCOL
  26. Usefulness of Mean Platelet Volume as a Biomarker for Long-Term Outcomes After Percutaneous Coronary Intervention
  27. The Role of Paramedics in a Primary PCI Program for ST-Elevation Myocardial Infarction
  28. MODERN ERA CORONARY ARTERY BYPASS GRAFT PATENCY: ANGIOGRAPHIC AND FUNCTIONAL OUTCOMES IN THE CASCADE MULTICENTER RANDOMIZED CONTROLLED TRIAL
  29. EARLY PCI AFTER THROMBOLYSIS VERSUS STANDARD THERAPY IN STEMI PATIENTS: A CUMULATIVE META-ANALYSIS
  30. ASSOCIATION OF CYP2C19*2 TO ALTERED CLOPIDOGREL REACTIVITY AS MEASURED BY A POINT-OF-CARE ANALYSIS
  31. SHORT- AND LONG-TERM OUTCOMES OF SYSTEMATIC PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WHO DEVELOP CARDIOGENIC SHOCK AFTER A ST-ELEVATION MYOCARDIAL INFARCTION (STEMI)
  32. ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarcti...
  33. A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction
  34. Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) a...
  35. Percutaneous coronary intervention for left main coronary artery disease
  36. Comparison of Early Mortality of Paramedic-Diagnosed ST-Segment Elevation Myocardial Infarction With Immediate Transport to a Designated Primary Percutaneous Coronary Intervention Center to That of Similar Patients Transported to the Nearest Hospital
  37. Percutaneous Coronary Intervention After Fibrinolysis
  38. Comparison of Mortality Patterns in Patients With ST-Elevation Myocardial Infarction Arriving by Emergency Medical Services Versus Self-Transport (from the Prospective Ottawa Hospital STEMI Registry)
  39. Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study)
  40. Commentary
  41. Safety of coronary stenting with eptifibatide and ultra-low-dose heparin
  42. Evaluation of myocardial perfusion using rubidium-82 positron emission tomography after myocardial infarction in patients receiving primary stent implantation or thrombolytic therapy
  43. Stenting versus thrombolysis in acute myocardial infarction trial (STAT)
  44. Usefulness of the electrocardiogram in predicting stent patency in patients presenting with chest pain within one month of coronary stenting
  45. Predictors of long-term outcome after stent implantation in a saphenous vein graft
  46. Late clinical and angiographic follow-up after stenting in evolving and recent myocardial infarction
  47. Usefulness of intracoronary stenting in acute myocardial infarction
  48. Refractory ventricular fibrillation complicating acute myocardial infarction terminated by intracoronary stenting
  49. Intracoronary stenting in the setting of myocardial infarction